Grants and Contributions:

Back to search

Title:

Next-Generation Resorbable and Long-Term Hollow/Porous Glass Microspheres for Precision Transarterial Embolization.

Agreement Number:

1030534

Agreement Value:

$314,512.00

Agreement Date:

May 5, 2025 - Aug 3, 2026

Description:

This project aims to develop resorbable hollow/porous/solid glass microspheres for precision transarterial embolization (TAE), with long-term variants as an additional option. Unlike permanent embolic agents, the resorbable radiopaque microspheres provide temporary occlusion, precise imaging, and safe, controlled degradation. Objectives include synthesizing tunable glass microsphere compositions, optimizing their structure for payload and delivery efficiencies, and confirming effectiveness in preclinical models. These versatile, biocompatible microspheres enhance TAE precision, minimize long-term risks for temporary embolization needs, and set a new benchmark in interventional radiology.

Organization:

National Research Council Canada

Expected Results:

The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization

Location:

Halifax, Nova Scotia, CA B3S 1B3

Reference Number:

172-2025-2026-Q1-1030534

Agreement Type:

Contribution

Report Type:

Grants and Contributions

Recipient Business Number:

829493089

Recipient Type:

For-profit organization

Recipient's Legal Name:

ABK BIOMEDICAL INCORPORATED

Federal Riding Name:

Halifax West

Federal Riding Number:

12006

Program:

Industrial Research Assistance Program – Contributions to Firms

Program Purpose:

Coverage:

IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.

NAICS Code:

339110